Financial Advocates Investment Management Guardant Health, Inc. Transaction History

Financial Advocates Investment Management

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $9,255 - $12,932	-212 Reduced 3.91%	5,209 $281,000
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $10,029 - $26,917	-348 Reduced 6.03%	5,421 $219,000
Q1 2022 May 11, 2022	BUY	$48.25 - $100.49 $10,856 - $22,610	225 Added 4.06%	5,769 $382,000
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $15,524 - $21,075	175 Added 3.26%	5,544 $555,000
Q3 2021 Nov 04, 2021	SELL	$98.77 - $132.17 $1,975 - $2,643	-20 Reduced 0.37%	5,369 $671,000
Q1 2021 May 10, 2021	SELL	$127.04 - $179.1 $42,558 - $59,998	-335 Reduced 5.85%	5,389 $823,000
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $22,491 - $30,584	-225 Reduced 3.78%	5,724 $738,000
Q3 2020 Nov 04, 2020	BUY	$80.32 - $111.8 $7,550 - $10,509	94 Added 1.61%	5,949 $665,000
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $2,419 - $3,900	40 Added 0.69%	5,855 $475,000
Q1 2020 Apr 29, 2020	SELL	$59.04 - $88.81 $1,476 - $2,220	-25 Reduced 0.43%	5,815 $405,000
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $33,909 - $47,184	570 Added 10.82%	5,840 $456,000
Q3 2019 Nov 13, 2019	BUY	$62.59 - $110.3 $13,143 - $23,163	210 Added 4.15%	5,270 $336,000
Q2 2019 Aug 08, 2019	BUY	$63.94 - $91.11 $145,463 - $207,275	2,275 Added 81.69%	5,060 $437,000
Q1 2019 May 16, 2019	BUY	$34.3 - $97.98 $19,036 - $54,378	555 Added 24.89%	2,785 $214,000
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $65,116 - $102,803	2,230 New	2,230 $83,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.